I have been asked to determine whether the clinical assessment of the patient with upper gastrointestinal bleeding can accurately predict diagnosis or outcome. The answer is "not very well with respect to diagnosis, not too bad with respect to outcome." To support that conclusion, I will consider the published literature first and then supplement it with preliminary data from a study we are conducting at three affiliated hospitals.
DIAGNOSIS
In a study by Cotton et al, the clinical history of dyspepsia, saticylate, or other drug ingestion, and chronic alcoholism in 208 patients was quite unreliable in predicting the source of bleeding (1) . Most useful was the history of dyspepsia, where 75% of those patients were found to have gastric or duodenal ulcers. However, ulcer disease was also found in approximately 35% of the patients who gave no such history. The history of salicylate ingestion or chronic alcoholism was little better than no history at all in predicting the eventual diagnosis. In the same study, age and sex were seldom helpful in predicting the source of bleeding. Women were more likely to have gastric than duodenal ulcers whereas the incidence was equal in men. However, in neither sex was one lesion seen to the exclusion of the other.
Perhaps more helpful is the clinical judgment that the patient who presents with an upper gastrointestinal bleed is suffering from liver disease. In a study reported from Harlem Hospital, a simple division of patients into those thought to be suffering from liver disease versus those who were not allowed one to distinguish patients who were unlikely to be bleeding from varices (2) . Within the group of patients who had clinical liver disease, however, variceal bleeding occurred in just 20%, and a Mallory-Weiss tear, ulcer disease, and erosive gastritis were found in the remainder. It is also remarkable that the distinction between patients having liver disease and those not having liver disease was associated with a rather remarkable difference in eventual mortality (25% in those with liver disease, 5% in the remainder).
In a study by Merigan et al, patients known to have cirrhosis were grouped according to the severity of bleeding (3) . Those patients judged to have 4 + bleeding had an admission packed-cell volume of less than 20 and were in shock. Those with 3 + bleeding had a packed-cell volume of between 20 and 29 and were not in shock. Lesser degrees of severity corresponded to higher presenting hematocrits. Variceal bleeding was more common in those who presented with severe bleeding, whereas bleeding from gastritis tended to be less marked.
We have evidence in the literature then, that the initial clinical assessment, ie, sex, presence or absence of liver disease, and the severity of the bleeding episode may serve to incriminate one diagnostic possibility over another, but the reliability of that prediction is poor. Perhaps the best we can do is to separate patients into those who are considered to have liver disease from those who are not and assume variceal bleeding would be unlikely without clinical liver disease. (4) . This was a large study consisting of 2139 patients admitted to one hospital over a 15-year period. Poor prognostic factors were advanced age, no previous history of gastrointestinal disease or apparent drug intake, hematemesis, hypotension, and a marked degree of anemia. Some of these factors, particularly age, hematemesis, and the evidence of a severe bleed are not particularly surprising. In this country, however, the absence of a previous gastrointestinal history would not be expected to be associated with an increase in mortality. In fact, the exact opposite is more likely because cirrhosis is such a major underlying contributor to gastrointestinal bleeding.
In the study by Merigan et al, increased severity of bleeding in patients with cirrhosis was associated quite clearly with an impressive increase in mortality (3). Indeed, those patients presenting with a hematocrit of less than 20 and in shock had a mortality of over 95%. Even more remarkable is the fact that the overall survival in this group of cirrhotic patients was less than 50%. This emphasizes the clinical utility of distinguishing patients who have liver disease on the basis of physical examination and past history because the prognosis in these patients is quite poor. These two studies demonstrate that there are characteristics of a patient population that allow one to predict increased mortality. However, the utility of these factors in predicting outcome for any given patient is less certain. In one study that considered this problem, the investigators studied 40 consecutive patients with upper gastrointestinal bleeding to identify factors that implied a poor prognosis (5). They noted that age, a past medical history of cardiac, respiratory, hepatic, or renal disease, or congestive heart failure were poor prognostic factors. The absence of an alcohol history or the absence of a drug intake were also bad prognostic factors. After distinguishing these prognostic factors on 40 consecutive patients, they then looked for them in a subsequent 66 patients who presented to their hospital. They found that those patients with one factor or less had a substantially better outcome than those with three or more factors. By using this simple scoring function they were able to achieve a prognostic accuracy for individual patients of approximately 90%. This was much better than the 50% rate noted when clinicians were asked to predict the outcome of ten of their cases. This last study provides some support for the concept that clinical assessment of the patient may very well be able to provide an accurate estimate of the eventual outcome. What is needed are similar studies in larger groups of patients followed prospectively. If a reliable and reasonably accurate system of outcome prediction can be formulated, it may serve to identify a subset of patients who warrant all-out diagnostic and therapeutic effort.
From the literature, then, the clinical assessment of the patient is rather poor in predicting the source of bleeding but may be more useful in predicting the outcome, At first glance, what appears most helpful is distinguishing those patients with evidence of liver disease from those without. Past history of aspirin intake and acute alcohol ingestion without clinical liver disease may be Useful in predicting a minor bleed and good survival. It seems very unlikely that a truly reliable System of prediction for outcome can be derived which is based simply on one clinical parameter. The only study addressing this issue required a score function based on five clinical characteristics to achieve 90% accuracy (5).
PROSPECTIVE STUDYmPRELIMINARY DATA
We have been considering some of these issues in a randomized prospective study. The study is designed to evaluate the impact of early diagnostic intervention in 300 patients with upper gastrointestinal bleeding. At the moment, we have 107 patients in the study and have preliminary data on the first 62.
The criteria for entry into the study are: (1) hematemesis, melena, or guaiac-positive nasogastric aspirate within the previous 24 hr; (2) the patient is a potential candidate for surgery or balloon tamponade; and (3) either postural hypotension or a PCV drop of >5 must be present.
These criteria were chosen to exclude the patient who has had a minor bleed and those in whom gastrointestinal bleeding is simply an incident in an obviously fatal course.
Patients who meet the criteria are randomized to immediate or delayed diagnostic groups. Endos- copy is done as soon as the patient's hemodynamic status is stable in the immediate group and between the 5th and 6th day of hospitalization in the delayed group. Patients randomized to the delayed diagnosis group undergo endoscopy sooner if their bleeding persists to such a degree that surgical intervention seems warranted. We have made no effort to contrast endoscopy versus upper gastrointestinal series or angiography. For put,poses of this study, we assume that endoscopy is the most accurate procedure and do it first. The procedure providing the diagnosis is shown on Table 1 . Not surprisingly, endoscopy was the most useful, upper gastrointestinal series was a distant second, equaled only by autopsy. Surgery provided the diagnosis in one patient, and a diagnosis was not possible in three patients. The probable or definite major source Of the bleeding is shown on Table 2 . We could be more certain in the immediate than the delayed diagnosis group. Esophagogastritis and ulcer disease were equally frequent and responsible for 70% of the bleeding. Varices were next most likely, followed by a Mallory-Weiss tear. Multiple lesions were not uncommon
As part of this study we have had the physicians who take care of these patients estimate the diagnosis and prognosis before and after endoscopic diagnosis. We use a form in which they are asked to choose no more than five possible diagnoses and to estimate the probability of that diagnosis in the given patient.
For example, a 36-year-old alcoholic patient with ascites, palpable spleen, known varices, and massive hematemesis enters the hospital. The physician taking care of the patient might estimate the diagnostic probabilities, in this particular case, as follows: 85% varices, 8% erosive gastritis, 3% Mallory-Weiss tear, 2% gastric ulcer, and 2% esophagitis. The probabilities add up to 100 out of 100. The physicians are also asked to estimate the outcome of the particular patient as follows: cessation of bleeding with or without surgical therapy, continued bleeding with medical therapy, surgery, or balloon tamponade. We have found that these choices have been sufficient to characterize the outcome of our first 62 patients. The physicians are also asked to estimate a probability of death. Now the question arises, how good are the physicians taking care of the patients in estimating the diagnosis and the prognosis of the patient? Secondly, what impact does time and endoscopic diagnosis have on these estimates? I might note at this point that we asked not only ourselves to make this guess, but we also asked the gastroenterology fellow and the medical resident to do it independently. It is not surprising to me that no one of us was much better than the others.
The probability figures assigned to the correct diagnosis upon admission are less than 40% in both groups (Table 3) . We are poor then in diagnosing the patient based on what we see, hear, and examine. By day 2 in the immediate group, an endoscopy has been performed and the diagnostic accuracy then rises to 89%. This gradually increases until by day 6 accuracy is almost 100%. The reasons for this gradual increase are additional x-ray studies and the occasional patient who goes to surgery. In the delayed group, diagnostic accuracy increases somewhat during the first four hospital days, but generally remains at a low level. After endoscopy on the fifth day, accuracy of diagnosis again increases dramatically.
Despite our inability to predict diagnosis in the group as a whole, there are some differences among various patient groups with or without evidence of gastrointestinal disease. Accuracy is least good in those who have no history of gastrointestinal disease and increases with any evidence that disease is present on history or physical examination. Past history of ulcer disease or symptoms suggestive of ulcer disease allow somewhat more accurate prediction of diagnosis than does the presence of liver disease. In all these groups, endoscopy dramatically increases the accuracy, however. In contrast, there seems to be little utility to a prior history of aspirin or alcohol intake. In fact, the worst diagnostic accuracy occurs in the patients who have taken both.
We have also looked at the eventual diagnosis to see if those patients have characteristics that allow a more accurate assessment of their diagnosis prior to knowing it. Here it appears that a diagnosis of ulcer disease is more accurately predicted prior to knowing that diagnosis than is the presence of varices or esophageal gastritis.
Our preliminary data confirm what has been known in the literature to date. We are pretty bad at predicting the diagnosis, but we are a little bit better if something about the patient suggests known gastrointestinal disease. There is not much improvement in diagnostic accuracy with observation in the hospital for 96 hr. It increases dramatically, however, with endoscopy, whether performed immediately or later in the course. Endoscopy is not the only necessary diagnostic tool to arrive at the final diagnosis, but used as we have, only 10% of patients require other studies.
As shown on Table 4 , we do somewhat better in predicting the patient's eventual hospital course. There is a steady improvement in prediction during the first 5 days of hospitalization, and there is no apparent influence of endoscopic diagnosis. We were least able to predict the course in those with clinical liver disease and were much better in those with evidence for ulcer disease or no previous gastrointestinal history. Although there was no apparent influence of endoscopy on the ability to prognosticate when all patients were considered as a whole, there is a suggestion that endoscopy may improve the ability to prognosticate in those patients who have liver disease.
The simple prediction of survival or death is quite good upon the first contact with the patient, presumably because so many patients survive this illness, These data are given in Table 5 . There is a gradual improvement during the 5 days of the study without apparent influence of endoscopic diagnosis. Unlike the prediction of hospital course, there appears to be no subset of patients with gastrointestinal disease in which endoscopy allows a distinct improvement in the prediction of death or survival.
We have also looked at whether the presence of clinical gastrointestinal disease on history and physical examination, the appearance of the nasogastric aspirate, postural hypotension, hematemesis, initial PCV, age, sex, or prothrombin time abnormalities can predict the eventual transfusion requirement, need for surgery, and mortality. The presence of liver disease by history and physical examination identifies the vast majority of patients who will require surgery and die. This dominant influence is reflected in all other parameters which predict eventual need for surgery and death. Not surprisingly, fresh bleeding represents a poor prognostic sign, although surgery and death can occur even when the initial nasogastric aspirate is clear. Postural hypotension is quite frequent in our study group, but it also appears to distinguish those patients who will require surgery and die. Interestingly enough, the median transfusion requirement is not much different in surviving or dying patients, which implies, perhaps, that the rate of bleeding is the critical issue. And finally, patients with variceal bleeding require the most transfusions, often require surgery, and die.
CONCLUSION
The preliminary results of our study can only be considered indications of what we might see when 300 patients have been enrolled. In general, the data confirm what has been reported in the literature and extend previous observations to some degree. When the patient presents to the hospital, the available history, physical examination, and laboratory data do not allow an accurate diagnosis of the source of the gastrointestinal bleeding. This capacity does not improve much with 4 days in the hospital. I believe the difficulties of accurate diagnosis can be attributed to the large number of possible bleeding lesions. It seems less likely that inadequacies in the hurried initial history and physical examination are responsible because accuracy does not improve much with 4 days of hospitalization.
These clinical observations, however, do allow a more confident estimate of hospital outcome and survival. This improves substantially during the hospital stay and is not apparently influenced (save for a possible subset of patients with clinical liver disease) by making a diagnosis. Here, the physician is helped in his estimates by the limited number of possible courses and the fact that most patients stop bleeding and survive the episode. Although the appearance of the nasogastric aspirate, presence of postural hypotension, and the diagnosis of variceal bleeding all correlate with the need for eventual surgery and increased mortality, evidence of clinical liver disease on history and physical examination seems the best discriminator. There is ample reason to suspect that our ability to prognosticate could be substantially improved with the sophisticated analysis of large-size prospective studies.
